ZWJ Investment Counsel’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,384
Closed -$205K 219
2024
Q4
$205K Buy
2,384
+491
+26% +$53.1K 0.01% 207
2024
Q3
$225K Hold
1,893
0.01% 206
2024
Q2
$270K Hold
1,893
0.01% 194
2024
Q1
$243K Buy
+1,893
New +$225K 0.01% 209
2021
Q1
Sell
-6,120
Closed -$214K 172
2020
Q4
$214K Buy
+6,120
New +$212K 0.01% 158
2020
Q2
Sell
-15,524
Closed -$467K 181
2020
Q1
$467K Sell
15,524
-1,248
-7% -$37.2K 0.04% 137
2019
Q4
$485K Buy
+16,772
New +$464K 0.03% 150

Other funds holding NVO

ZWJ Investment Counsel's NVO Position: Q1 2025 in Review

ZWJ Investment Counsel sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,384 shares — an estimated $205K sold.

ZWJ Investment Counsel first reported a position in NVO in Q4 2019 and held it in 7 quarters. The position peaked at $485K in Q4 2019. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • ZWJ Investment Counsel reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • ZWJ Investment Counsel sold 2,384 Novo Nordisk shares in Q1 2025, an estimated $205K.
  • ZWJ Investment Counsel first reported a position in Novo Nordisk in Q4 2019 and held it in 7 quarters.
  • ZWJ Investment Counsel's Novo Nordisk position peaked at $485K in Q4 2019.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on ZWJ Investment Counsel's 13F filing for Q1 2025, filed 28 Apr 2025.